Index tracked: Bloomberg 2027 Maturity USD Corporate Bond Screened Index
TER
0.12%+ trans. 0.03%
Fund size
10 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Duration
0.81 yrsshort (≤3 years)
Launch 8 Jul 2025 · costs from the KID as of 14 Aug 2026 · 524 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to provide exposure to the performance of USD denominated investment grade corporate bonds each with an effective maturity in 2027. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective the Fund will seek to replicate the total return performance of the Bloomberg 2027 Maturity USD Corporate Bond Screened Index (the "Index"), less fees, expenses and transaction costs. The Fund will employ sampling techniques to select securities in the Index which may include but…
Performance since series start (in euro) — base 100
8 Jul 2025 → 12 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 106 (16 Jul 2026) · low 99 (25 Jul 2025) · last 106. Past performance is not indicative of future results.
RebalixB27X · IE000JUB0QM2 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it
The live sheet, always up to date rebalix.com/en/etf/IE000JUB0QM2 Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.